JP2011506941A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011506941A5 JP2011506941A5 JP2010537302A JP2010537302A JP2011506941A5 JP 2011506941 A5 JP2011506941 A5 JP 2011506941A5 JP 2010537302 A JP2010537302 A JP 2010537302A JP 2010537302 A JP2010537302 A JP 2010537302A JP 2011506941 A5 JP2011506941 A5 JP 2011506941A5
- Authority
- JP
- Japan
- Prior art keywords
- seprase
- cancer
- esophagus
- colon
- stomach
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100023832 Prolyl endopeptidase FAP Human genes 0.000 claims 15
- 108010072257 fibroblast activation protein alpha Proteins 0.000 claims 15
- 239000012634 fragment Substances 0.000 claims 13
- 229920001184 polypeptide Polymers 0.000 claims 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims 12
- 238000000034 method Methods 0.000 claims 11
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 10
- 208000026900 bile duct neoplasm Diseases 0.000 claims 10
- 210000001072 colon Anatomy 0.000 claims 10
- 210000003238 esophagus Anatomy 0.000 claims 10
- 210000003128 head Anatomy 0.000 claims 10
- 210000004072 lung Anatomy 0.000 claims 10
- 210000003739 neck Anatomy 0.000 claims 10
- 230000000694 effects Effects 0.000 claims 6
- 108010036226 antigen CYFRA21.1 Proteins 0.000 claims 5
- 210000000013 bile duct Anatomy 0.000 claims 5
- 238000001514 detection method Methods 0.000 claims 5
- 208000014829 head and neck neoplasm Diseases 0.000 claims 5
- 210000002966 serum Anatomy 0.000 claims 5
- 210000002784 stomach Anatomy 0.000 claims 5
- 201000000498 stomach carcinoma Diseases 0.000 claims 5
- 206010004593 Bile duct cancer Diseases 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 208000006990 cholangiocarcinoma Diseases 0.000 claims 4
- 206010017758 gastric cancer Diseases 0.000 claims 4
- 208000026037 malignant tumor of neck Diseases 0.000 claims 4
- 201000011549 stomach cancer Diseases 0.000 claims 4
- 101000603202 Homo sapiens Nicotinamide N-methyltransferase Proteins 0.000 claims 3
- 102100038951 Nicotinamide N-methyltransferase Human genes 0.000 claims 3
- 239000003153 chemical reaction reagent Substances 0.000 claims 3
- NJHLGKJQFKUSEA-UHFFFAOYSA-N n-[2-(4-hydroxyphenyl)ethyl]-n-methylnitrous amide Chemical compound O=NN(C)CCC1=CC=C(O)C=C1 NJHLGKJQFKUSEA-UHFFFAOYSA-N 0.000 claims 3
- 239000003550 marker Substances 0.000 claims 2
- 230000003247 decreasing effect Effects 0.000 claims 1
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07023897A EP2071337A1 (en) | 2007-12-10 | 2007-12-10 | Seprase as a marker for cancer |
| EP07023897.7 | 2007-12-10 | ||
| EP08015310 | 2008-08-29 | ||
| EP08015310.9 | 2008-08-29 | ||
| PCT/EP2008/010385 WO2009074275A1 (en) | 2007-12-10 | 2008-12-08 | Seprase as a marker for cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011506941A JP2011506941A (ja) | 2011-03-03 |
| JP2011506941A5 true JP2011506941A5 (enExample) | 2011-10-06 |
| JP5563988B2 JP5563988B2 (ja) | 2014-07-30 |
Family
ID=40373548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010537302A Expired - Fee Related JP5563988B2 (ja) | 2007-12-10 | 2008-12-08 | 癌のマーカーとしてのセプラーゼ |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8980573B2 (enExample) |
| EP (1) | EP2223115B1 (enExample) |
| JP (1) | JP5563988B2 (enExample) |
| KR (1) | KR101202220B1 (enExample) |
| CN (1) | CN101896818B (enExample) |
| AT (1) | ATE524740T1 (enExample) |
| AU (1) | AU2008335855B2 (enExample) |
| BR (1) | BRPI0820793A2 (enExample) |
| CA (1) | CA2706115A1 (enExample) |
| DK (1) | DK2223115T3 (enExample) |
| ES (1) | ES2372442T3 (enExample) |
| MX (1) | MX2010004671A (enExample) |
| PL (1) | PL2223115T3 (enExample) |
| WO (1) | WO2009074275A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8213005B2 (en) | 2003-07-22 | 2012-07-03 | King Saud University | Method for discriminating between benign and malignant prostate tumors |
| JP5298188B2 (ja) * | 2008-07-03 | 2013-09-25 | エフ．ホフマン−ラ ロシュ アーゲー | 肺癌用マーカーとしてのａｓｃ |
| JP5763098B2 (ja) | 2009-12-20 | 2015-08-12 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
| DK2666872T3 (en) | 2010-02-05 | 2016-07-25 | Astute Medical Inc | Methods and compositions for the diagnosis and prognosis of renal injury and renal insufficiency |
| CA2815356A1 (en) * | 2010-10-20 | 2012-04-26 | Rush University Medical Center | Lung cancer tests |
| ES2578477T3 (es) * | 2011-03-11 | 2016-07-27 | Roche Diagniostics Gmbh | ASC como marcador de la enfermedad pulmonar obstructiva crónica (EPOC) |
| EP2684049A1 (en) * | 2011-03-11 | 2014-01-15 | Roche Diagniostics GmbH | Seprase as marker for chronic obstructive pulmonary disease (copd) |
| CN102435748B (zh) * | 2011-11-25 | 2014-07-16 | 广东药学院 | 一种双抗夹心酶联免疫检测试剂盒及其制备方法 |
| WO2013086359A1 (en) | 2011-12-08 | 2013-06-13 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| KR20150023904A (ko) | 2012-06-27 | 2015-03-05 | 버그 엘엘씨 | 전립선암의 진단 및 치료에서의 마커의 용도 |
| US9250242B2 (en) | 2012-11-09 | 2016-02-02 | Roche Molecular Systems, Inc. | In vitro capture and analysis of circulating tumor cells |
| KR20150090240A (ko) * | 2012-11-30 | 2015-08-05 | 어플라이드 프로테오믹스, 인크. | 결장 종양의 존재 또는 위험의 평가 방법 |
| CA3158996C (en) | 2013-01-17 | 2024-06-04 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US9753037B2 (en) | 2013-03-15 | 2017-09-05 | Rush University Medical Center | Biomarker panel for detecting lung cancer |
| CN103267852B (zh) * | 2013-05-15 | 2015-03-25 | 中国医学科学院北京协和医院 | 成纤维激活蛋白α在制备胰腺癌预后试剂盒中的用途 |
| KR101619122B1 (ko) | 2013-08-14 | 2016-05-10 | 연세대학교 산학협력단 | 탈메틸화 의존적 ａｓｃ 발현을 촉진시켜서 대장암 종양세포의 사멸감수성을 증진시키는 항암제 병용 투여용 후보물질의 스크리닝 방법 |
| WO2015088947A1 (en) | 2013-12-09 | 2015-06-18 | Rush University Medical Center | Biomarkers of rapid progression in advanced non-small cell lung cancer |
| PL230661B1 (pl) * | 2014-01-29 | 2018-11-30 | Centrum Onkologii Inst Im Marii Sklodowskiej Curie Oddzial W Gliwicach | Metoda predykcyjna in vitro do przewidywania i/lub wykluczenia obecnosci raka pluc, zastosowanie in vitro metody predykcyjnej oraz zestaw testowy do wykrywania in vitro raka pluc |
| EP2916134B1 (en) | 2014-03-05 | 2017-08-16 | Roche Diagnostics GmbH | Use of Seprase for differential diagnosis of acute dyspnea |
| SG11201704660YA (en) | 2014-12-08 | 2017-07-28 | Berg Llc | Use of markers including filamin a in the diagnosis and treatment of prostate cancer |
| WO2016146174A1 (en) * | 2015-03-17 | 2016-09-22 | Biontech Ag | Compositions and methods for diagnosis and treatment of cancer |
| GB2545361B (en) | 2015-04-10 | 2018-01-24 | Applied Proteomics Inc | Methods of assessing colorectal cancer status |
| JP2018035137A (ja) | 2016-07-13 | 2018-03-08 | マブイミューン ダイアグノスティックス エイジーＭａｂｉｍｍｕｎｅ Ｄｉａｇｎｏｓｔｉｃｓ Ａｇ | 新規な抗線維芽細胞活性化タンパク質（ｆａｐ）結合薬剤およびその使用 |
| CA3029926C (en) * | 2016-07-25 | 2023-01-03 | Shizuoka Prefecture | Diagnostic biomarker for extrahepatic bile duct cancer, intrahepatic bile duct cancer or gallbladder cancer |
| WO2018111989A1 (en) | 2016-12-14 | 2018-06-21 | Purdue Research Foundation | Fibroblast activation protein (fap)-targeted imaging and therapy |
| DE102017010455A1 (de) * | 2017-06-13 | 2018-12-13 | Forschungszentrum Jülich GmbH | Verfahren zum Nachweis von Aggregaten biotherapeutischer Substanzen in einer Probe |
| CA3074684A1 (en) * | 2017-09-05 | 2019-03-14 | Oncotag Diagnostics Co., Ltd. | Method for diagnosing pancreatic cancer using methionyl-trna synthetase, and pancreatic cancer diagnostic kit using same |
| WO2022007283A1 (zh) * | 2020-07-08 | 2022-01-13 | 深圳霁因生物医药转化研究院 | 用于诊断fap表达异常相关疾病的试剂盒、方法及计算机可读存储介质 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0953639A1 (en) * | 1998-04-30 | 1999-11-03 | Boehringer Ingelheim International GmbH | FAPalpha-specific antibody with improved producibility |
| CN104531529A (zh) * | 2003-10-31 | 2015-04-22 | 维特克公司 | 用于检测循环肿瘤和内皮细胞的血液测试样机和方法 |
| US7968308B2 (en) * | 2004-10-22 | 2011-06-28 | Danisco Us Inc. | Isolating human antibodies |
| EP1760076A1 (en) * | 2005-09-02 | 2007-03-07 | Ferring B.V. | FAP Inhibitors |
| CA2633803A1 (en) * | 2005-12-19 | 2007-09-07 | Trustees Of Tufts College | Soft protease inhibitors and pro-soft forms thereof |
-
2008
- 2008-12-08 BR BRPI0820793-3A patent/BRPI0820793A2/pt not_active IP Right Cessation
- 2008-12-08 JP JP2010537302A patent/JP5563988B2/ja not_active Expired - Fee Related
- 2008-12-08 WO PCT/EP2008/010385 patent/WO2009074275A1/en not_active Ceased
- 2008-12-08 AU AU2008335855A patent/AU2008335855B2/en not_active Ceased
- 2008-12-08 CA CA2706115A patent/CA2706115A1/en not_active Abandoned
- 2008-12-08 EP EP08859952A patent/EP2223115B1/en active Active
- 2008-12-08 ES ES08859952T patent/ES2372442T3/es active Active
- 2008-12-08 PL PL08859952T patent/PL2223115T3/pl unknown
- 2008-12-08 CN CN200880119930.1A patent/CN101896818B/zh active Active
- 2008-12-08 AT AT08859952T patent/ATE524740T1/de active
- 2008-12-08 KR KR1020107012678A patent/KR101202220B1/ko not_active Expired - Fee Related
- 2008-12-08 MX MX2010004671A patent/MX2010004671A/es active IP Right Grant
- 2008-12-08 DK DK08859952.7T patent/DK2223115T3/da active
-
2010
- 2010-06-02 US US12/791,946 patent/US8980573B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011506941A5 (enExample) | ||
| US20230116530A1 (en) | Method for detecting nucleosomes containing histone variants | |
| Lim et al. | An electrochemical peptide sensor for detection of dengue fever biomarker NS1 | |
| Wang et al. | Detection of prostate specific antigen in whole blood by microfluidic chip integrated with dielectrophoretic separation and electrochemical sensing | |
| CA2845993C (en) | Method for detecting nucleosomes containing nucleotides | |
| US20220214345A1 (en) | Colorectal cancer screening examination and early detection method | |
| MX2008009592A (es) | Metodos y composiciones para identificar pacientes con una probabilidad incrementada de tener cancer de ovario. | |
| JP2008529008A5 (enExample) | ||
| WO2006036788A3 (en) | Methods and compositions for evaluating breast cancer prognosis | |
| IL192866A (en) | Detecting cancer with high levels of 2 bcl | |
| Jainish et al. | Biosensors and biomarkers: promising tools for cancer diagnosis | |
| JP2013521763A5 (enExample) | ||
| Dong et al. | A highly sensitive colorimetric aptasensor for the detection of the vascular endothelial growth factor in human serum | |
| WO2008151110A3 (en) | Molecular diagnosis and typing of lung cancer variants | |
| CN103898205A (zh) | 半胱氨酸蛋白酶抑制剂sn的应用 | |
| Wang et al. | MXenes-Au NPs modified electrochemical biosensor for multiple exosome surface proteins analysis | |
| Sousa et al. | Recent advances in the selection of cancer-specific aptamers for the development of biosensors | |
| Park et al. | Subunit-specific mass spectrometry method identifies haptoglobin subunit alpha as a diagnostic marker in non-small cell lung cancer | |
| Lin et al. | An enzyme-free fluorescent biosensor for highly sensitive detection of carcinoembryonic antigen based on aptamer-induced entropy-driven circuit | |
| CN103278621A (zh) | 一种利用生物传感器与血糖仪检测转录因子的方法 | |
| Wang et al. | An ultrasensitive label-free electrochemical impedimetric immunosensor for vascular endothelial growth factor based on specific phage via negative pre-screening | |
| Chen et al. | Electrochemical identification of hepatocellular carcinoma based on the assay of human cervical cancer oncoprotein-1 in serum | |
| Ye et al. | Nanostructures and nanotechnologies for the detection of extracellular vesicle | |
| Morace et al. | Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma? | |
| ATE462803T1 (de) | Kit und verfahren zum nachweis von urothelkarzinom |